Close Menu

Waters

The $11 billion in stimulus funding provided earlier this year could be just the first step of a planned major overhaul of how life science research in Japan is funded, changes that include the creation of a Japanese NIH. But some are questioning if the proposals can have a meaningful impact.

NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the third quarter were up 2 percent year over year, with weak pharma sales countering improved government and academic demand.

NEW YORK (GenomeWeb News) – Investment firm Mizuho today downgraded Waters, citing "choppiness around the pharmaceutical market" that may cause the company's stock to "languish."

According to a study led by researchers at Technical University Munich, the addition of an inexpensive solvent to electrospray ionization mass spectrometry runs could offer a significant improvement in peptide identification by LC-MS/MS.

Waters said this week that Douglas Berthiaume plans to retire from his position as CEO of the company sometime in the next two years.

NEW YORK (GenomeWeb News) – Informatics firm Nonlinear Dynamics said today that it has been purchased by Waters.

NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the second quarter were flat year over year, as it experienced a late-quarter slowdown in instrument systems orders.

NEW YORK (GenomeWeb News) – William Blair on Thursday initiated coverage of Waters, saying it believes the company can continue on its path of revenue growth and noting Waters consumables business and emerging market presence.

A team led by researchers at the University of Washington has developed a multiplexed approach to data-independent acquisition mass spec that could offer significant gains in precursor selectivity.

NEW YORK (GenomeWeb News) – Waters has entered into a new credit agreement to provide the company $1.4 billion in debt financing.

Pages

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.